Detailed answers about NEXORA MEDICAL AFFAIRS LIMITED, including incorporation, status, business activity, and accounts information.
When was NEXORA MEDICAL AFFAIRS LIMITED founded?
NEXORA MEDICAL AFFAIRS LIMITED was officially incorporated on 12 May 2017 and is registered under company number 10768510. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is NEXORA MEDICAL AFFAIRS LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of NEXORA MEDICAL AFFAIRS LIMITED?
NEXORA MEDICAL AFFAIRS LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does NEXORA MEDICAL AFFAIRS LIMITED do?
NEXORA MEDICAL AFFAIRS LIMITED operates in the following sector: 74909 - Other professional, scientific and technical activities n.e.c.. This provides insight into the company's primary business activity and industry focus.
What is NEXORA MEDICAL AFFAIRS LIMITED's registered address?
The registered office address of NEXORA MEDICAL AFFAIRS LIMITED is 58 Abbey Gardens, London, Greater London, England, W68QR. This is the official address filed with Companies House for legal and statutory correspondence.
Is NEXORA MEDICAL AFFAIRS LIMITED financially stable?
The most recent accounts for NEXORA MEDICAL AFFAIRS LIMITED were made up to 31 May 2025, filed as UNAUDITED ABRIDGED. Next accounts are due by 28 February 2027.
Has NEXORA MEDICAL AFFAIRS LIMITED changed its name?
Yes, NEXORA MEDICAL AFFAIRS LIMITED has had 1 previous name: COSMETISTA LIMITED (changed 2 November 2026).